The Medtronic iPro2 CGM is ultra compact & light weight device that was built for blinded clinical trials. It's design and technology provide continuous glucose monitoring (CGM) without patient daily interaction. The small recorder design records interstitial glucose levels in persons with diabetes for up to 144 hours of continuous wear.
Benefit of iPro2 for clinical trials
- Ready blinded to prevent patient bias and interventions
- Checked every 6 days to ensure patient safety is prioritised
- Compact and lightweight reducing the patient burden
- The design provides the sustainable reuse of the recorder across trial subjects